Skip to content

Shire

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2015

    Shire completes acquisition of Meritage Pharma

    Shire acquired Meritage Pharma for an upfront fee of $70 million, plus contingent payments tied to development and regulatory milestones. The acquisition included global rights to Meritage's Oral Budesonide Suspension compound and further development of it.